Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1984 Dec;77(12):1023–1029. doi: 10.1177/014107688407701207

Tumour immunology: a review.

P J Lachmann
PMCID: PMC1440179  PMID: 6439868

Full text

PDF
1023

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brickell P. M., Latchman D. S., Murphy D., Willison K., Rigby P. W. Activation of a Qa/Tla class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse. Nature. 1983 Dec 22;306(5945):756–760. doi: 10.1038/306756a0. [DOI] [PubMed] [Google Scholar]
  2. FOLEY E. J. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953 Dec;13(12):835–837. [PubMed] [Google Scholar]
  3. Golstein P., Rubin B., Denizot F., Luciani M. F. Xenoserum-induced cytolytic "T" cells: polyclonal specificity with an apparent "anti-self" component, and cooperative induction. Immunobiology. 1979 Aug;156(1-2):121–137. [PubMed] [Google Scholar]
  4. Greaves M. F. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res. 1981 Nov;41(11 Pt 2):4752–4766. [PubMed] [Google Scholar]
  5. Harris H. The carapace of the cancer cell. The Osler oration 1984. J R Coll Physicians Lond. 1984 Jul;18(3):161–165. [PMC free article] [PubMed] [Google Scholar]
  6. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  7. Kärre K., Klein G. O., Kiessling R., Klein G., Roder J. C. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature. 1980 Apr 17;284(5757):624–626. doi: 10.1038/284624a0. [DOI] [PubMed] [Google Scholar]
  8. Lennox E. S., Lowe A. D., Cohn J., Evan G. Specific antigens on methylcholanthrene-induced tumors of mice. Transplant Proc. 1981 Dec;13(4):1759–1761. [PubMed] [Google Scholar]
  9. Medawar P. B., Hunt R. Vulnerability of methylcholanthrene-induced tumours to immunity aroused by syngeneic foetal cells. Nature. 1978 Jan 12;271(5641):164–165. doi: 10.1038/271164a0. [DOI] [PubMed] [Google Scholar]
  10. Metcalfe S., Milner J., Svvennsen R. J. A new indicator of human malignant tumour. Br J Cancer. 1984 Mar;49(3):337–342. doi: 10.1038/bjc.1984.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moss D. J., Rickinson A. B., Wallace L. E., Epstein M. A. Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature. 1981 Jun 25;291(5817):664–666. doi: 10.1038/291664a0. [DOI] [PubMed] [Google Scholar]
  12. Prehn R. T. The immune reaction as a stimulator of tumor growth. Science. 1972 Apr 14;176(4031):170–171. doi: 10.1126/science.176.4031.170. [DOI] [PubMed] [Google Scholar]
  13. Rickinson A. Epstein-Barr virus in epithelium. Nature. 1984 Jul 12;310(5973):99–100. doi: 10.1038/310099a0. [DOI] [PubMed] [Google Scholar]
  14. Roder J., Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 1979 Mar 29;278(5703):451–453. doi: 10.1038/278451a0. [DOI] [PubMed] [Google Scholar]
  15. Rojko J. L., Olsen R. G. The immunobiology of the feline leukemia virus. Vet Immunol Immunopathol. 1984 May;6(1-2):107–165. doi: 10.1016/0165-2427(84)90050-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schlager S. I., Ohanian S. H., Borsos T. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid. J Immunol. 1978 Feb;120(2):463–471. [PubMed] [Google Scholar]
  17. Terman D. S., Yamamoto T., Mattioli M., Cook G., Tillquist R., Henry J., Poser R., Daskal Y. Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowans I. I. Description of acute tumoricidal response: morphologic, histologic, immunohistochemical, immunologic, and serologic findings. J Immunol. 1980 Feb;124(2):795–805. [PubMed] [Google Scholar]
  18. Vyakarnam A., Lachmann P. J., Sikora K. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice. Immunology. 1981 Feb;42(2):337–348. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES